Financhill
Back

Climb Bio, Inc. Stock Predictions

Climb Bio, Inc. Stock Forecast

  • Is Climb Bio, Inc. Stock Undervalued?
    The current Climb Bio, Inc. [CLYM] share price is $4.85. The Score for CLYM is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • CLYM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Climb Bio, Inc. Stock Go Up Next Year?

Data Unavailable

Climb Bio, Inc. Stock Rating

Data Unavailable

Climb Bio, Inc. Stock Price History

Is CLYM stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLYM is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
climbbio.com

52-Week Data

52-Week High:
5.05
52-Week Low:
1.05

Prediction Charts

Market Cap:
330.7M
Price in USD:
4.85
Volume:
323K
Beta:
-0.06

Technical Analysis

SMA50:
2.29
SMA100:
2.18
SMA200:
1.74
52-Wk Change:
144.95%

Stock Predictions

  • Is Climb Bio, Inc. stock public?
    Yes, Climb Bio, Inc. is a publicly traded company.
  • What is the Climb Bio, Inc. stock quote today?
    The Climb Bio, Inc. stock price is 4.85 USD today.
  • How to buy Climb Bio, Inc. stock online?
    You can buy Climb Bio, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-4 1.73 1.73 1.77 1.71
Dec-5 1.72 1.72 1.74 1.69
Dec-8 1.73 1.81 1.84 1.73
Dec-9 1.81 1.90 1.94 1.80
Dec-10 1.90 2.08 2.13 1.89
Dec-11 2.07 2.30 2.31 2.07
Dec-12 2.31 3.00 3.25 2.30
Dec-15 3.14 3.81 4.82 3.08
Dec-16 3.61 4.62 4.64 3.56
Dec-17 4.52 4.25 4.52 3.79
Dec-18 4.33 4.38 4.60 4.04
Dec-19 4.36 4.28 4.63 4.13
Dec-22 4.33 4.90 4.93 4.26
Dec-24 4.59 4.85 4.96 4.50

Climb Bio, Inc. Earnings

Data Unavailable

Climb Bio, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

* Climb Bio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.